Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net earnings, including noncontrolling interest $ 263,099 $ 139,585 $ 229,296
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 101,069 87,747 82,737
Costs recognized on sale of acquired inventory 1,596 1,565  
Deferred income taxes 6,816 (27,431) 13,130
Stock-based compensation expense 42,183 48,982 32,367
Fair value adjustment to contingent consideration payable (20,400) 5,300 (905)
Contingent consideration payments - operating (3,300) (337) (958)
Fair value adjustment on available for sale investments (15,002) 67,879 (137,527)
Asset impairment restructuring 546    
Eminence impairment 18,715    
Leases, net (1,201) 75 225
Gain on escrow settlement     (7,169)
Other operating activity 668 (464) (732)
Change in operating assets and operating liabilities, net of acquisition:      
Trade accounts and other receivables, net (57,596) (15,549) 6,556
Inventories (32,007) (7,140) (14,861)
Prepaid expenses (3,082) (1,101) (2,605)
Trade accounts payable, accrued expenses, contract liabilities, and other 12,741 19,091 10,343
Salaries, wages and related accruals 7,760 20,536 2,552
Income taxes payable 2,667 13,426 (7,231)
Net cash provided by (used in) operating activities 325,272 352,164 205,217
CASH FLOWS FROM INVESTING ACTIVITIES:      
Proceeds from maturities of available-for-sale investments 26,055 66,377 147,120
Purchases of available-for-sale investments (52,998) (39,684) (70,187)
Additions to property and equipment (44,908) (44,301) (51,744)
Acquisitions, net of cash acquired   (225,352)  
Investment in unconsolidated entity, net   (556) 1,906
Investment of forward purchase contract (25,000)    
Net cash provided by (used in) investing activities (96,851) (243,516) 27,095
CASH FLOWS FROM FINANCING ACTIVITIES:      
Cash dividends (50,185) (49,622) (48,902)
Proceeds from stock option exercises 77,155 65,092 70,983
Re-purchases of common stock (160,950) (43,178) (50,112)
Borrowings under line-of-credit agreement 90,000 256,000 40,000
Payments on line-of-credit (175,500) (271,500) (188,500)
Contingent consideration payments - financing (700)   (3,400)
Taxes paid on RSUs and net share settlements (23,461) (19,343) (3,872)
Other financing activity 788    
Net cash provided by (used in) financing activities (242,853) (62,551) (183,802)
Effect of exchange rate changes on cash and cash equivalents (12,092) 6,369 (2,771)
Net change in cash and cash equivalents (26,524) 52,466 45,739
Cash and cash equivalents at beginning of period 199,091 146,625 100,886
Cash and cash equivalents at end of period $ 172,567 $ 199,091 $ 146,625